How many institutions held PYXS - Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share in Q2 2026?

4 institutional investors reported PYXS - Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share for Q2 2026. Use the holders table for investor-level position and value details.

Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS)

Q: What does CUSIP 747324101 represent in this 13F holders report?

CUSIP 747324101 is the security identifier for PYXS - Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 747324101

Q2 2026 13F Holders as of 30 Jun 2026

Security type / class: Equity / Common Stock, par value $0.001 per share
Total 13F shares: 11,276
Total 13F value: $33,791
Share change: +2,085
SEC-reported price per share: $3.01
Number of holders: 4
Value change: +$6,126
Number of buys: 1
Number of sells: 1
Shares outstanding: 83,452,472

Security key

747324101

Report period

Q2 2026

Institutions

Top holders

PYXS full security history Ownership snapshot Full 13F holder table Previous quarter: Q1 2026 Pyxis Oncology, Inc. SEC filings Pyxis Oncology, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 747324101

Previous quarter: Q1 2026

Recent filing periods:

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024

Ownership snapshot

Top reported holders of PYXS - Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

GordonMD Global Investmen...

Disclosed value leader

GordonMD Global Investmen...

Comparable rows

15/15

Latest evidence

30 Jun 2026

13D/G 3/4/5 13F Lead comparable stake: 12% 13D/G row: GordonMD Global Investments LP Showing 1-6 of 15 holder rows.

Quick read

GordonMD Global Investments LP leads the comparable SEC ownership view at 12%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens GordonMD Global Investments LP's linked filing trail.

Comparable ownership Top 5

GordonMD Global Investments LP 12%

Lara Sullivan 11%

Laurion Capital Management LP 7.7%

INTEGRATED CORE STRATEGIES (US) LLC 4%

BlackRock, Inc. 1.5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
GordonMD Global Investments LP	13D/G 3/4/5 13F 10%+ Owner · Company 13D/G 3/4/5 13F	12%	$22,856,793 10,024,909 shares	+$14,113,585	30 Jun 2026
Lara Sullivan	13D/G 3/4/5 Lara Sullivan, M.D. · President ,CEO & CMO, Director 13D/G 3/4/5	11%	$7,844,727 7,543,007 shares	+$955,040	31 Mar 2025
Laurion Capital Management LP	13D/G 13F Company 13D/G 13F	7.7%	$9,880,747 4,796,479 shares	$0	31 Dec 2025
INTEGRATED CORE STRATEGIES (US) LLC	13D/G Millennium Management LLC 13D/G	4%	$2,587,602 2,488,079 shares	-$698,942	31 Mar 2025
BlackRock, Inc.	13D/G 13F Company 13D/G 13F	1.5%	$2,192,635 926,805 shares	-$5,718,934	30 Jun 2025
MILLENNIUM MANAGEMENT LLC	13D/G 13F Company 13D/G 13F	1.3%	$1,497,185 818,134 shares	-$4,985,888	30 Sep 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

11,276

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders

Q2 2026 holders

Holder diff

-72

Investor	Q1 2026 Shares	Q2 2026 Shares	Share Diff	Share Chg %	Q1 2026 value	Q2 2026 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend